{
    "status": "OK",
    "copyright": "Copyright (c) 2025 The New York Times Company. All Rights Reserved.",
    "response": {
        "docs": [
            {
                "abstract": "Rather than bargain with a single maker, the pharmacy benefits manager says it will offer both Repatha and Praluent, promising but expensive products.",
                "web_url": "https://www.nytimes.com/2015/10/07/business/express-scripts-says-it-will-cover-2-new-cholesterol-drugs.html",
                "snippet": "Rather than bargain with a single maker, the pharmacy benefits manager says it will offer both Repatha and Praluent, promising but expensive products.",
                "lead_paragraph": "The nation\u2019s largest manager of drug prescriptions said on Tuesday that it would pay for two drugs in a promising new class of cholesterol-lowering medicines, rather than choose one over the other in an effort to lower costs.",
                "print_section": "B",
                "print_page": "4",
                "source": "The New York Times",
                "multimedia": [],
                "headline": {
                    "main": "Express Scripts Says It Will Cover 2 New Cholesterol Drugs",
                    "kicker": null,
                    "content_kicker": null,
                    "print_headline": "Express Scripts Will Cover 2 New Cholesterol Drugs",
                    "name": null,
                    "seo": null,
                    "sub": null
                },
                "keywords": [
                    {
                        "name": "organizations",
                        "value": "Express Scripts Inc",
                        "rank": 1,
                        "major": "N"
                    },
                    {
                        "name": "subject",
                        "value": "Drugs (Pharmaceuticals)",
                        "rank": 3,
                        "major": "N"
                    },
                    {
                        "name": "subject",
                        "value": "Repatha (Drug)",
                        "rank": 4,
                        "major": "N"
                    },
                    {
                        "name": "subject",
                        "value": "Praluent (Drug)",
                        "rank": 5,
                        "major": "N"
                    },
                    {
                        "name": "subject",
                        "value": "Cholesterol",
                        "rank": 6,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "AbbVie Inc",
                        "rank": 7,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "Sanofi SA",
                        "rank": 8,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "Gilead Sciences Inc",
                        "rank": 9,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "Amgen Inc",
                        "rank": 10,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "Regeneron Pharmaceuticals Inc",
                        "rank": 11,
                        "major": "N"
                    }
                ],
                "pub_date": "2015-10-06T21:00:42+0000",
                "document_type": "article",
                "news_desk": "Business",
                "section_name": "Business Day",
                "byline": {
                    "original": "By Andrew Pollack",
                    "person": [
                        {
                            "firstname": "Andrew",
                            "middlename": null,
                            "lastname": "Pollack",
                            "qualifier": null,
                            "title": null,
                            "role": "reported",
                            "organization": "",
                            "rank": 1
                        }
                    ],
                    "organization": null
                },
                "type_of_material": "News",
                "_id": "nyt://article/1d43e58f-d265-5687-8309-22251685ed46",
                "word_count": 772,
                "uri": "nyt://article/1d43e58f-d265-5687-8309-22251685ed46"
            }
        ],
        "meta": {
            "hits": 1,
            "offset": 0,
            "time": 7
        }
    }
}